Fig 4B shows that the adsorption inhibitor DS-8000 and the CXCR4 antagonist AMD3100 lose their activity when administered 30–45 minutes post-infection. TE-2 showed a profile resembling that of the fusion inhibitor enfuvirtide (T-20) (Fig 4B). This evidence concerns the gene CXCR4 and infection.